Bank of America Strategists Warn Fed Hikes in Pricey Market to End Poorly

image

(Bloomberg) — Optimists expecting the stock market to weather the rate-hike cycle as they’ve done in the past are missing one important detail, according to Bank of America Corp.’s strategists.

While U.S. equities saw positive returns during previous periods of rate increases, the key risk this time round is that the Federal Reserve will be “tightening into an overvalued market,” the strategists led by Savita Subramanian wrote in a note.

“The S&P 500 is more expensive ahead of the first rate hike than any other cycle besides 1999-00,” they said.

U.S. and European stocks have made a rocky start to 2022 amid concerns that more aggressive monetary steps to tame inflation will hamper the recovery. While a positive earnings season is easing some worries over a less forgiving macroeconomic backdrop, equity markets have remained volatile, and strategists are divided about what lies ahead for the rest of the year.

BofA’s team is squarely in the bears’ camp, expecting the U.S. benchmark to end the year at 4,600 points, implying just 2% upside from current levels. The strategists argue that the closest historical precedent to the present outlook is the monetary tightening at the turn of the century, which “ended poorly” for stocks with the bursting of the tech bubble.

“The pivot from super dovish to more hawkish policy underscores that we are at the point of peak liquidity,” they said in the note on Monday.

While other notable Wall Street voices, including Morgan Stanley’s Michael Wilson, share their pessimism, the assessment is by no means the consensus view. JPMorgan Chase & Co.’s team reiterated on Monday that growth will remain solid this year and with still more upside for equities, following the ferocious rally of 2021.

For BofA’s strategists, though, an abundance of red flags including valuations, sentiment, fundamentals and technical factors point to a poor year for equities.

“Moreover, we believe that risks to equities would be greater if the Fed did nothing,” they wrote. “Runaway inflation would likely compress S&P 500 multiples and cut into earnings.”

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More